Screener
Nektar Therapeutics NKTR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.06B.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's market capitalization?
- Nektar Therapeutics (NKTR) reported market capitalization of $2.06B in Q1 2026.
- How has Nektar Therapeutics's market capitalization changed year-over-year?
- Nektar Therapeutics's market capitalization increased by 1531.0% year-over-year, from $126.55M to $2.06B.
- What is the long-term trend for Nektar Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Nektar Therapeutics's market capitalization has grown at a -22.8% compound annual growth rate (CAGR), from $3.14B to $860.04M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Nektar Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude